News at Home

Investment

Industry players in the field of biotechnology have much to rejoice as venture capital and private equity manager, Commerce-Ventures teamed up with Bank Negara Malaysia to launch their new 15 year, RM350 million agri-business funding initiatives called Commerce Agro Ventures Fund and Commerce Khazanah-Ventures. Launched by Agriculture and Agro-based Industries Minister Tan Sri Muhyiddin Yassin, the fund would be invested in agriculture-based activities targeting investee companies in four key industries, namely fisheries, livestock farming, industrial and horticulture crop farming, and agro-biotechnology and food technology. The RM150 million fund would be focused on upstream and downstream industries, as well as early stage companies, while the RM200 million fund is for technology-based capital requiring intensive capital.

 

Similarly, there has been an influx of foreign investments with the recent push by the government for the biotech industry as various countries vie for a slice of the local biotechnology pie. Among them, Taiwanese bioindustries look set to pick Malaysia as its springboard into other Asian countries citing the advantages of political and economical stability. On the other hand, other foreign endeavors that seems to be falling into place are commitments from British investments and Dutch-based agrobusiness bank , Rabobank’s anticipated plunge into the Malaysian Agriculture sector.

 
Medical
 
Frustrated by the death of patients due to prolonged diagnosis from meliodosis, a bacterial infection, microbiologist Alex Francis decided to take things into his own hands, through research. After dedicating work on the disease, the nightmare of long waiting periods for diagnostic tests seem to be ending with the discovery of a media which allows for faster diagnostic time for the infection. The media, which takes only 18 hours to diagnose the disease compared to the 72 hours using conventional MacConkey, Ashdown and Blood Agar, is to be known after its inventor as Francis Media.
 
In other news, the Health Ministry has allocated RM26 million to set up a state of the art laboratory dedicated to the diagnosis and prevention of outbreaks. The laboratory, the first of its kind in the Asia Pacific region, will be set up at Sungai Buloh and was recently handed over after being commissioned since Dec 1, 2004. Specimens would be sent to the laboratory for clinical research, diagnosis and tests to ascertain what indigenous or exotic agents is causing disease outbreaks.
Industry
In a move to reward commitment and excellence in commercial practices, healthcare company INS Bioscience Bhd (INSBio) has been awarded the award for Excellence in Biotechnology-based Manufacturing at the inaugural Technology Business Review Awards. The award is aimed at identifying and rewarding companies for achieving excellence in their business sectors with the use of technology as an innovating factor.
 
However, other industry players are not sitting by idly, as we can observe robust growth from leading biomedical firm, StemLife. The company forecasts an increase in profits by almost two-fold, from RM3.8 million in 2006 to RM6.1 million in 2007, riding high on improved business in Thailand, Indonesia and back home. On the other hand, Innobiologics have been slated to gain an edge by tapping into more regional opportunities via its long term collaboration with UK-based GE Healthcare.
 
             
Policy
As countries begin to look for other alternatives sources of fuel to quench the thirst for more crude oil imports, China, Thailand and India are actively looking for ethanol as an effective offset to crude oil dependence. However, Tsinghua University academic Professor Lixin Fu maintains that a more concerted effort is needed for effective and efficient production of the alternative fuel source.
             
Environmentalists and ethics activists in the country, as well as the people can heave a sigh of relief as a proposal to set up the National BioSafety Board is anticipated to be tabled in Parliament by early next year. The board, once established will be responsible for approving the import and export of biological products.